Intrum (OM:INTRUM) has come into focus after its second quarter 2026 earnings showed lower revenue and profit year on year, along with a net loss for the first half. The stock has moved sharply over recent months as investors reassess the company’s progress.
Over the past month Intrum has seen a 22.10% 30 day share price return and an 8.51% 7 day share price return. However, this short term momentum sits against a much weaker picture, with a 90 day share price return that fell 79.68% and a 1 year total shareholder return that declined 60.03% as investors weighed the latest earnings, capital raise and credit rating upgrade against ongoing operational challenges.
Spot opportunities that echo Intrum's recent volatility by screening for other companies with compressed valuations and solid fundamentals using the 267 high quality undervalued stocks.Intrum still runs a sizeable credit and collection business across Europe, yet the share price collapse and recent rebound raise a sharper question: Are investors looking at a mispriced recovery story or a value trap in plain sight?
Against Intrum's last close at SEK3.90, the most followed narrative applies a fair value of SEK15.63 and sees a wide gap between price and projected earnings power.
Disciplined but rising investment volumes in the portfolio business, underpinned by performance above original collection curves and strong IRRs, can stabilize the shrinking book and eventually return investing income and cash EBITDA to growth.
Read the complete narrative. Read the complete narrative.
Curious what sits behind that valuation gap? The narrative leans on earnings turning around, margins rebuilding, and a future profit multiple that looks unusually low against those targets.
Result: Fair Value of SEK15.63 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Intrum still carries high leverage near SEK45b and relies on shrinking investing portfolios, so any setback in deleveraging or deal flow could quickly test this recovery case.
Find out about the key risks to this Intrum narrative.
With such a split picture around Intrum, it helps to move quickly from headlines to hard data and form your own judgment. To weigh both sides of the story, start by checking the 3 key rewards and 3 important warning signs.
Do not stop your research with Intrum. Fresh ideas often come from comparing similar opportunities and seeing where quality, valuation and balance sheet strength line up.
Use the Simply Wall St Screener to quickly surface other stocks that fit what you are looking for.267 high quality undervalued stocks
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com